Umbilical cord-derived stem cells (MODULATISTTM) show strong immunomodulation capacity compared to adipose tissue-derived or bone marrow-derived mesenchymal stem cells. Biomedical Research and Therapy, [S. l.], v. 3, n. 06, p. 687–696, 2016. Disponível em: https://preservation.bmrat.org/index.php/BMRAT/article/view/103.. Acesso em: 15 nov. 2024.